Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.

MLA

Hung, Chin-Sheng, et al. “Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.” International Journal of Molecular Sciences, vol. 19, no. 10, Oct. 2018. EBSCOhost, https://doi.org/10.3390/ijms19103096.

APA

Hung, C.-S., Wang, S.-C., Yen, Y.-T., Lee, T.-H., Wen, W.-C., & Lin, R.-K. (2018). Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target. International Journal of Molecular Sciences, 19(10). https://doi.org/10.3390/ijms19103096

Chicago

Hung, Chin-Sheng, Sheng-Chao Wang, Yi-Ting Yen, Tzong-Huei Lee, Wu-Che Wen, and Ruo-Kai Lin. 2018. “Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.” International Journal of Molecular Sciences 19 (10). doi:10.3390/ijms19103096.